-transparent.png){kind=logo}
Healthy volunteers received a single dose of triazolam (0.5 mg) or oxazepam (30 mg) on two occasions, once in the control state and again during coadministration of isoniazid (INH) base, 180 mg day. INH coadministration prolonged triazolam half-life (3.3 vs 2.5 h, P less than 0.05) and increased total area under the curve (38.6 vs 26.5 ng ml-1 h, P less than 0.01) consistent with a reduction of apparent oral clearance (3.9 vs 6.8 ml min-1 kg-1, 0.05 less than P less than 0.1). INH coadministration had no influence on the kinetics of oxazepam. INH impairs hepatic microsomal oxidation of triazolam, leading to reduced first-pass hepatic extraction as well as prolonged half-life. However INH had no influence on oxazepam conjugation.
H R Ochs, and
D J Greenblatt, and
M Knüchel
January 1990,
Pharmacology,
H R Ochs, and
D J Greenblatt, and
M Knüchel
June 1968,
Archives of general psychiatry,
H R Ochs, and
D J Greenblatt, and
M Knüchel
January 1993,
International clinical psychopharmacology,
H R Ochs, and
D J Greenblatt, and
M Knüchel
January 1988,
Psychopharmacology,
H R Ochs, and
D J Greenblatt, and
M Knüchel
January 1977,
Acta pharmacologica et toxicologica,
H R Ochs, and
D J Greenblatt, and
M Knüchel
January 1983,
Physiologia Bohemoslovaca,
H R Ochs, and
D J Greenblatt, and
M Knüchel
March 1983,
The Journal of pharmacology and experimental therapeutics,
H R Ochs, and
D J Greenblatt, and
M Knüchel
November 2002,
Drug metabolism and disposition: the biological fate of chemicals,
H R Ochs, and
D J Greenblatt, and
M Knüchel
July 1997,
Biochemical pharmacology,
H R Ochs, and
D J Greenblatt, and
M Knüchel
June 1983,
The Journal of laboratory and clinical medicine,
